Xenon Pharmaceuticals (XENE) is up 46.5%, or $19.49 to $61.43.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XENE:
- Biohaven fractionally lower after Xenon reports azetukalner Phase 3 hit target
- Xenon Pharmaceuticals rises 41.8%
- Morning Movers: Hims & Hers skyrockets following agreement with Novo
- Xenon Pharmaceuticals: Strong X-TOLE2 Data and Blockbuster Potential for Azetukalner Support Buy Rating
- Xenon’s Azetukalner Hits Phase 3 Mark in Focal Onset Seizures, Paving Way for FDA Filing